Home | e-Alert Archives | ProductsBecome a Premium Member | Forum | Members Archive | Site MapOctober 6, 2008



  Log-in
  Member Alert
   Archives

  Ask the Experts
  Community 
   Forum


  Welcome to HSI
  Our Mission
  HSI Research 
   Experts
  Success Stories
  Contact Us



  Northstar 
   Nutritionals
  Healthy 
   Solutions
  Recommended 
   Books

 Privacy Policy
 FAQ
 Guarantee
 Disclaimer

start WP import block

Getting Ahead of Relief

When the big guns aren't effective, it may be time to go back and give some simple tools a try. That's the finding of a new study that tested dietary supplements on patients who had been unsuccessful in relieving migraines with a variety of drugs.

Antioxidant rescue

Could free radical damage contribute to migraine headaches? Dr. Sirichai Chayasirisobhon of Kaiser Permanente Medical Center set out to address that question when he recruited a dozen patients, each with a long-term history of little or no success at treating migraines with various drugs, including antidepressants, beta-blockers and anticonvulsants.

At the outset of the study, subjects completed a migraine disability assessment (MIDAS) questionnaire to assess the impact of migraine flare-ups on activities at home, at work and while interacting with friends and family. For the three-month trial period, each subject received daily supplements that contained 600 mg of vitamin C, 300 IU of vitamin E and 1,200 mg of a pine bark extract. Subjects were allowed to continue using whatever medications they were currently taking.

When subjects completed a second MIDAS questionnaire at the end of the study period, their responses indicated marked improvement. And even though the lack of a control group opens the possibility of placebo effect, the results were promising:

  • The overall MIDAS score improvement was more than 50 percent
  • Average Number of migraine days was reduced from 44 days in the three months prior to supplementation, to just 26 days during the trial period
  • Average migraine severity score was reduced from 7.5 (out of 10) to 5.5 

One subject dropped out of the trial. Of the remaining 11, two reported no change in migraine frequency, duration or severity. Among the other nine, the overall MIDAS score improvement was nearly 68 percent.

411 on CoQ10

So…what's up with this pine bark extract?

Although not identified in the study, I believe the extract is almost certainly Pycnogenol; a natural antioxidant extracted from French maritime pine bark. Pycnogenol contains a variety of polyphenols with anti-inflammatory properties that have been shown to benefit the cardiovascular system by promoting proper blood flow. In the July 1998 HSI Members Alert, we compared the effectiveness of Pycnogenol's antioxidant qualities to two of the most powerful antioxidants: glutathione and coenzyme Q10 (CoQ10).

In fact, Dr. Chayasirisobhon might have produced even more impressive migraine relief if he had added CoQ10 to the supplement mix.

In a CoQ10 trial conducted in 2002, 32 migraine patients each received 150 mg of the antioxidant daily for three months. In the month before the study began, the group experienced an average of more than seven days of migraine each. But by the end of the study that monthly average had dropped to just under three days. About 60 percent of the subjects reported that their frequency of migraines dropped to less than half of what it had been before the study.

And in the e-alert "Power to the Powerhouses" (6/28/04), I told you about a Swiss study in which 42 migraine patients received either 100 mg of CoQ10 three times each day, or a placebo. No other methods were used to prevent migraines. After three months of supplementation, researchers found that migraine frequency, total days with migraine, and total days with nausea were all significantly reduced in the CoQ10 group, compared to placebo. Overall, the incidence of migraines was almost cut in half in the CoQ10 group, while the reduction of migraines in the placebo group was less than 15 percent.

When this research was presented at the 2004 annual meeting of the American Academy of Neurology, the Swiss team noted that migraines might be triggered by a breakdown in the production of cellular energy. They theorized that CoQ10 helps prevent migraines by promoting proper respiration in the powerhouses of the cell: the mitochondria.

If you suffer from migraines, talk to your doctor or a healthcare professional about these promising antioxidant studies before expanding your supplement regimen.

Sources: 
"Use of a Pine Bark Extract and Antioxidant Vitamin Combination Product as Therapy for Migraine in Patients Refractory to Pharmacologic Medication" Headache: The Journal of Head and Face Pain, Vol. 46, No. 5, May 2006, Blackwell-synergy.com
"Antioxidant Combo May Prevent Some Migraines" Reuters Health, 6/1/06, reutershealth.com

end WP import block

Sign-up to receive the free
HSI e-Alert daily e-letter.

Privacy policy




HSI Only Special Reports

 >> Defeat Heart Disease 

 >> Ultimate HRT Alternative
 >> Weight loss solutions
 >> Drive out toxins
 >> Covering up your skin?
 >> Boost your immunity

 >> Prevent prostate problems

 >> Multiple Sclerosis relief
 >> Goodbye to arthritis
 >> Dangerous parasites

 >> Fight fatigue

Get more alternative medicine breakthroughs in the Member Alert.


back to top

Health Disclaimer!  The information provided on this site should not be construed as personal medical advice or instruction. No action should be taken based solely on the contents of this site. Readers should consult appropriate health professionals on any matter relating to their health and well-being. The information and opinions provided here are believed to be accurate and sound, based on the best judgment available to the authors, but readers who fail to consult appropriate health authorities assume the risk of any injuries. The publisher is not responsible for errors or omissions.



Copyright © 1997 - 2007 by Institute of Health Sciences, L.L.C.